Compare LYEL & DAVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | DAVEW |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | United States | United States |
| Employees | N/A | 274 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | N/A |
| IPO Year | 2021 | N/A |
| Metric | LYEL | DAVEW |
|---|---|---|
| Price | $23.95 | $0.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 96.7K | 12.3K |
| Earning Date | 01-01-0001 | 03-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | $61,000.00 | ★ $319,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | N/A | ★ 30.00 |
| 52 Week Low | $0.39 | $0.12 |
| 52 Week High | $45.00 | $2.73 |
| Indicator | LYEL | DAVEW |
|---|---|---|
| Relative Strength Index (RSI) | 45.81 | 51.85 |
| Support Level | $21.27 | $0.26 |
| Resistance Level | $27.30 | $1.04 |
| Average True Range (ATR) | 2.27 | 0.07 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 41.28 | 78.79 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.